312 related articles for article (PubMed ID: 17763048)
1. The application of non-default uncertainty factors in the U.S. EPA's Integrated Risk Information System (IRIS). Part I: UF(L), UF(S), and "other uncertainty factors".
Stedeford T; Zhao QJ; Dourson ML; Banasik M; Hsu CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):245-79. PubMed ID: 17763048
[TBL] [Abstract][Full Text] [Related]
2. Utilizing uncertainty factors in minimal risk levels derivation.
Pohl HR; Abadin HG
Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
[TBL] [Abstract][Full Text] [Related]
3. Approaches to cancer assessment in EPA's Integrated Risk Information System.
Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
[TBL] [Abstract][Full Text] [Related]
4. Proposal of new uncertainty factor application to derive tolerable daily intake.
Hasegawa R; Hirata-Koizumi M; Dourson ML; Parker A; Sweeney LM; Nishikawa A; Yoshida M; Ono A; Hirose A
Regul Toxicol Pharmacol; 2010 Nov; 58(2):237-42. PubMed ID: 20561553
[TBL] [Abstract][Full Text] [Related]
5. Lack of total independence of uncertainty factors (UFs): implications for the size of the total uncertainty factor.
Calabrese EJ; Gilbert CE
Regul Toxicol Pharmacol; 1993 Feb; 17(1):44-51. PubMed ID: 8441828
[TBL] [Abstract][Full Text] [Related]
6. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
Pohl HR; Chou CH; Ruiz P; Holler JS
Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
[TBL] [Abstract][Full Text] [Related]
7. Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.
Stelljes ME; Wood RR
Regul Toxicol Pharmacol; 2004 Oct; 40(2):136-50. PubMed ID: 15450717
[TBL] [Abstract][Full Text] [Related]
8. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
9. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
10. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
Davis JA; Gift JS; Zhao QJ
Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
[TBL] [Abstract][Full Text] [Related]
11. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
12. Human health risk assessment database, "the NHSRC toxicity value database": supporting the risk assessment process at US EPA's National Homeland Security Research Center.
Moudgal CJ; Garrahan K; Brady-Roberts E; Gavrelis N; Arbogast M; Dun S
Toxicol Appl Pharmacol; 2008 Nov; 233(1):25-33. PubMed ID: 18692516
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
[TBL] [Abstract][Full Text] [Related]
14. Quantitative approaches to human risk assessment for noncancer health effects.
Kimmel CA
Neurotoxicology; 1990; 11(2):189-98. PubMed ID: 2234540
[TBL] [Abstract][Full Text] [Related]
15. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
16. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
17. The U.S. Environmental Protection Agency's risk assessment guidelines.
Jarabek AM; Farland WH
Toxicol Ind Health; 1990 Oct; 6(5):199-216. PubMed ID: 2274984
[TBL] [Abstract][Full Text] [Related]
18. Bayesian methods for uncertainty factor application for derivation of reference values.
Simon TW; Zhu Y; Dourson ML; Beck NB
Regul Toxicol Pharmacol; 2016 Oct; 80():9-24. PubMed ID: 27211295
[TBL] [Abstract][Full Text] [Related]
19. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
20. Science and decisions: advancing risk assessment.
Abt E; Rodricks JV; Levy JI; Zeise L; Burke TA
Risk Anal; 2010 Jul; 30(7):1028-36. PubMed ID: 20497395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
